Isabel Zaror
Novartis (United States)(US)
Publications by Year
Research Areas
Bacterial Genetics and Biotechnology, RNA and protein synthesis mechanisms, Glycosylation and Glycoproteins Research, PI3K/AKT/mTOR signaling in cancer, Bacteriophages and microbial interactions
Most-Cited Works
- → Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer(2011)249 cited
- → Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors(2017)40 cited
- → Baculovirus-driven protein expression in insect cells: A benchmarking study(2018)34 cited
- → Abstract 4498: Biological characterization of NVP-BKM120, a novel inhibitor of phosphoinosotide 3-kinase in Phase I/II clinical trials(2010)32 cited
- → Inhibition of prenylated KRAS in a lipid environment(2017)31 cited
- → Subset of Hybrid Eukaryotic Proteins Is Exported by the Type I Secretion System of Erwinia chrysanthemi(2001)30 cited
- → Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit(2017)26 cited
- → Fructose‐1,6‐bisphosphatase of the yeast Kluyveromyces lactis(1993)15 cited
- → The nucleotide sequence of theSalmonella typhiompC porin gene(1988)14 cited
- → High-level soluble expression, purification and characterization of active human midkine from Escherichia coli(2009)11 cited